Stock Surge: Merck & Co Inc (MRK) Closes at 100.73, Marking a -0.91 Increase/Decrease

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Merck & Co Inc (NYSE: MRK) closed at $100.73 down -0.91% from its previous closing price of $101.65. In other words, the price has decreased by -$0.91 from its previous closing price. On the day, 9.5 million shares were traded. MRK stock price reached its highest trading level at $103.23 during the session, while it also had its lowest trading level at $100.605.

Ratios:

For a deeper understanding of Merck & Co Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.80.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Bernstein on October 17, 2024, initiated with a Mkt Perform rating and assigned the stock a target price of $115.

On March 11, 2024, Societe Generale Downgraded its rating to Sell which previously was Hold but kept the price unchanged to $104.

TD Cowen Upgraded its Market Perform to Outperform on January 04, 2024, whereas the target price for the stock was revised from $125 to $135.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 11 ’24 when Merck & Co., Inc. bought 21,397,205 shares for $23.00 per share. The transaction valued at 492,135,715 led to the insider holds 1,000 shares of the business.

Litchfield Caroline sold 38,291 shares of MRK for $4,805,520 on Feb 14 ’24. The EVP & CFO now owns 50,908 shares after completing the transaction at $125.50 per share. On Feb 13 ’24, another insider, Davis Robert M, who serves as the Chairman, CEO & President of the company, sold 150,000 shares for $125.85 each. As a result, the insider received 18,877,424 and left with 348,327 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRK now has a Market Capitalization of 255331434496 and an Enterprise Value of 281831342080. As of this moment, Merck’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.10, and their Forward P/E ratio for the next fiscal year is 10.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.06 while its Price-to-Book (P/B) ratio in mrq is 5.86. Its current Enterprise Value per Revenue stands at 4.461 whereas that against EBITDA is 8.898.

Stock Price History:

Over the past 52 weeks, MRK has reached a high of $134.63, while it has fallen to a 52-week low of $98.60. The 50-Day Moving Average of the stock is -9.54%, while the 200-Day Moving Average is calculated to be -17.31%.

Shares Statistics:

For the past three months, MRK has traded an average of 9.19M shares per day and 9987310 over the past ten days. A total of 2.53B shares are outstanding, with a floating share count of 2.53B. Insiders hold about 0.10% of the company’s shares, while institutions hold 78.92% stake in the company. Shares short for MRK as of 1728950400 were 26041803 with a Short Ratio of 2.83, compared to 1726185600 on 24814031. Therefore, it implies a Short% of Shares Outstanding of 26041803 and a Short% of Float of 1.0299999.

Dividends & Splits

According to the company, the forward annual dividend rate for MRK is 3.08, from 3.04 in the trailing year. Against a Trailing Annual Dividend Yield of 0.029906541The stock’s 5-year Average Dividend Yield is 2.9.

Most Popular